15 companies

2invest

Market Cap: €67.3m

An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally.

2INV

€12.20

7D

-3.2%

1Y

40.2%

Merck KGaA

Market Cap: €50.2b

Operates as a science and technology company in Germany.

MRK

€115.35

7D

-2.0%

1Y

-31.5%

Cantourage Group

Market Cap: €80.3m

Operates as a medical cannabis company in Europe.

HIGH

€6.44

7D

11.0%

1Y

-10.6%

Apontis Pharma

Market Cap: €96.6m

Engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.

APPH

€11.60

7D

2.7%

1Y

41.8%

SCHOTT Pharma KGaA

Market Cap: €4.2b

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.

1SXP

€28.10

7D

-5.9%

1Y

-1.5%

Liminal BioSciences

Market Cap: €11.8m

Liminal BioSciences Inc., a development stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom.

PJ2

€3.80

7D

0%

1Y

-0.7%

4SC

Market Cap: €14.4m

A biopharmaceutical company, engages in developing small-molecule drugs that address cancer diseases with high unmet medical needs in Germany.

VSC

€1.32

7D

-26.7%

1Y

-82.4%

Evotec

Market Cap: €1.2b

Operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.

EVT

€7.02

7D

-1.3%

1Y

-17.4%

Formycon

Market Cap: €399.9m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

FYB

€22.65

7D

-0.7%

1Y

-46.8%

Biofrontera

Market Cap: €15.1m

A biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.

B8FK

€2.49

7D

-5.7%

1Y

-31.5%

Darwin

Market Cap: €89.4m

Operates as a biotechnology company.

New

7V0

€29.80

7D

0%

1Y

-17.7%

bioXXmed

Market Cap: €211.7k

An investment company, invests in biotechnology or medical technology companies with equity or debt capital.

T5O0

€0.41

7D

0%

1Y

-92.4%

Heidelberg Pharma

Market Cap: €160.8m

A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, the United States, and internationally.

HPHA

€3.45

7D

5.5%

1Y

18.2%

MPH Health Care

Market Cap: €111.7m

An investment company, engages in the healthcare business in Germany.

93M1

€25.40

7D

0.8%

1Y

-19.1%

Medigene

Market Cap: €1.3m

A biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer.

New

MDG1

€0.08

7D

-28.4%

1Y

-96.7%